We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

ortex-logo-h
​
​
Nasdaq:COAG
​
​
logo

Hemab Therapeutics Holdings (COAG)

Nasdaq • COAG • US4234941031

49.02Last close
Market Closed
Overview
Fundamentals
Events
News
Corp Actions
Index
Analysts
EPS Momentum
Holders
Dividend
Options
Shorts
Insiders
Peers
Commodity Exp
Trading Signals
Stock Scores

ORTEX Data Highlights

As of Oct 22, 2026, ORTEX estimated 21.1% of free float sold short, 10.5 days to cover, cost to borrow 2.32%. Sign up for live short interest data.

Market Cap

2.29b USD | # 3683 in US

Volume

458.57k shares | 18.55m USD

Shares Outstanding

46.71m

Free Float Shares

43.48% | 20.31m

News

COAG key data

Hemab Therapeutics Holdings (Nasdaq: COAG) has a market capitalization of $2.29B. Last close $49.02 (as of 2026-11-09); 52-week range $23.00 to $55.42. ORTEX data as of 2026-10-22: short interest was 21.11% of free float, 10.5 days to cover and the average cost to borrow was 2.32%. Sign up for live short interest data.

  • COAG news on ORTEX News
  • ORTEX News
  • ORTEX public data
  • ORTEX Charts
  • ORTEX API

© 2026 ORTEX Technologies Ltd.